Recent news coverage includes general market commentary on AI and technology stocks, with no direct recent news specifically about Target Group Inc.

• Recent market news highlights trends in artificial intelligence and technology stocks, with no direct mention of Target Group Inc. [N1]
• Chipmakers and AI stocks experienced declines in recent trading sessions, reflecting broader market volatility [N2]
• Long-term investor interest is noted in certain technology stocks, but no specific updates on Target Group Inc. [N3]

The company benefits from its licensed production capacity in Canada and exclusive agreements for proprietary cannabis genetics, positioning it to serve the growing Canadian cannabis market. Its integration of research, product development, and manufacturing capabilities supports product innovation. Ownership of patented vaporizer technology through CannaKorp Inc. could provide product differentiation. The company's strategic acquisitions and licensing agreements may enable expansion of its product portfolio and market reach within legal cannabis markets.

Target Group Inc. faces significant regulatory risks due to the evolving and uncertain legal landscape for cannabis, especially in the United States where cannabis remains federally illegal. The company reported a net loss and low liquidity ratios as of June 30, 2026, indicating financial challenges. High current liabilities relative to current assets suggest liquidity constraints. The company's reliance on related party debt and complex repayment terms may pose financial risks. Market competition and regulatory changes could adversely affect operations and financial condition.

Target Group Inc.'s moat is primarily based on its licensed production facilities in Canada, exclusive distribution and licensing agreements for proprietary cannabis seed strains, and its integration of research, testing, and product development capabilities. Its ownership of patented vaporizer technology through CannaKorp Inc. adds to its product differentiation. The company's established relationships and licenses under Canada's Cannabis Act provide regulatory compliance advantages in a heavily regulated industry. However, the cannabis market remains competitive and subject to evolving regulations, which may limit the durability of these advantages.

• Regulatory and Legal Risks: The cannabis industry is subject to evolving, uncertain, and potentially adverse regulations, particularly in the U.S. where cannabis remains federally illegal. Changes in enforcement or legislation could restrict operations, increase compliance costs, or reduce demand.
• Financial and Liquidity Risks: As of June 30, 2026, the company has a low current ratio of 0.17 and a cash ratio of 0.05, indicating liquidity constraints. The company reported a net loss for the quarter and relies on related party debt with complex repayment terms, which may impact financial stability.
• Market and Competitive Risks: The cannabis market is competitive and rapidly evolving. The company's ability to maintain exclusive agreements and product differentiation may be challenged by competitors and market changes.

• Target Group Inc. is a Canadian cannabis company engaged in cultivation, processing, and distribution of cannabis products for medical and adult-use recreational markets in Canada.
• The company was incorporated in Delaware in 2013 and changed its name to Target Group Inc. in 2018.
• Target Group's common stock trades on the OTC Pink Market under ticker CBDY since July 1, 2025.
• The company focuses on wholesale and co-packaging services for cannabis consumer-packaged goods, integrating cannabinoid research, analytical testing, product development, and manufacturing.
• Product manufacturing includes cannabis flower pods, extract pods, pre-rolls, infused beverages, edibles, topical products, and CBD wellness products.
• Target Group owns subsidiaries including Visava Inc./Canary Rx Inc., a licensed Canadian cannabis producer with a 44,000 sq ft facility in Ontario capable of growing up to 4 million grams annually.
• The company acquired CannaKorp Inc., which developed The Wisp™ vaporizer system and pods, continuing as a subsidiary.
• Target Group has an exclusive distribution and licensing agreement with Serious Seeds B.V. for proprietary cannabis seed strains and products in Canada and other legal markets globally.
• The company has licenses to cultivate, process, and sell cannabis under Canada's Cannabis Act, with production capacity of approximately 3,600 kg dried flower per year at Canary's facility.
• Target Group's financial snapshot as of June 30, 2026, shows current assets of $2.37 million, current liabilities of $13.6 million, cash and equivalents of $730,930, a current ratio of 0.17, and a cash ratio of 0.05.
• The company reported a net loss of $239,812 and basic and diluted EPS of -$0.0004 for the quarter ended June 30, 2026.
• As of August 13, 2026, the company had 617,025,999 shares of common stock issued and outstanding.
• The company has related party debt agreements with CL Investors Inc. secured by assets and stock pledges, with repayment schedules tied to net revenue.
• Target Group does not have operations, employees, or offices in the United States as of the latest report.
• The cannabis industry is subject to evolving and uncertain regulations, especially in the U.S. where cannabis remains federally illegal, posing regulatory risks to the company.
• Recent news coverage includes general market and AI stock commentary but no direct recent news specifically about Target Group Inc.
• Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.